Non-Alcoholic SteatoHepatitis (NASH)
89
6
14
51
Key Insights
Highlights
Success Rate
86% trial completion
Published Results
28 trials with published results (31%)
Research Maturity
51 completed trials (57% of total)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 49/100
9.0%
8 terminated out of 89 trials
86.4%
-0.1% vs benchmark
8%
7 trials in Phase 3/4
55%
28 of 51 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 51 completed trials
Clinical Trials (89)
A Study to Test Whether Survodutide Helps People Living With Obesity or Overweight and With a Confirmed or Presumed Liver Disease Called Non-alcoholic Steatohepatitis (NASH) to Reduce Liver Fat and to Lose Weight (SYNCHRONIZE-MASLD)
Evaluating the Pharmacokinetics and Safety of Miricorilant
A Phase 2b, Study Evaluating Miricorilant in Adult Patients With Nonalcoholic Steatohepatitis/Metabolic Dysfunction-Associated Steatohepatitis (MONARCH)
Simultaneous Quantification of Liver Fat Content, Fatty Acid Composition, and Fibrosis Using Spin-lock MRI for Steatohepatitis Assessment
A Clinical Study to Evaluate the Efficacy and Safety of Aramchol in Subjects With NASH (ARMOR)
Evaluation of Miricorilant on Liver Fat in Patients With MASLD
To Evaluate the Efficacy and Safety of HSK31679 in Chinese Patients With Non-Alcoholic Steatohepatitis (NASH) .
Stimulating Fat Tissue Storage With Niacin to Reduce Fat Accumulation in the Liver.
IMPACT TRIAL: Efficacy and Safety of Pemvidutide in Subjects With Nonalcoholic Steatohepatitis (NASH)
Exploratory Study to Assess the Short Term Effect on Liver Enzymes and the Safety of TRO19622 in Patients With Non-Alcoholic Steatohepatitis (NASH)
Efficacy and Tolerability of a Specialized Food Products for Dietary Therapeutic and Preventive Nutrition Based on Ice Cream (Ice Cream With Brazzein, Maltitol and Oligofructose; Ice Cream With Brazzein, Erythritol, Maltitol and Inulin) Compared to Standard (Sundae) Ice Cream
Non-alcoholic Fatty Liver Disease Parametric PET (FLiPP) Study
A Physiologic Analysis of Endoscopic Sleeve Gastroplasty (ESG)
A Study to Assess the Safety and Tolerability of Single Doses of AZD4076 in Healthy Male Subjects
A Study of BOS-580 in Obese Subjects at Risk for, or With Biopsy-confirmed, Nonalcoholic Steatohepatitis (NASH) With an Extension
A Study of FT 4101 in Overweight/Obese Participants With Non-alcoholic Steatohepatitis
Study of ADI-PEG 20 Versus Placebo in Subjects With NASH
Empagliflozin Versus Statins in Non-Alcoholic Fatty Liver Disease
How Abnormal Function of Fat Tissue in Type 1 Diabetes Contributes to Fat in the Liver
A Trial to Learn if Receiving ALN-PNP siRNA is Safe and Well Tolerated, and How it Works in Adult Participants With Nonalcoholic Fatty Liver Disease (NAFLD) and a Genetic Risk Factor